Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A multicentre, randomised, double-blind, placebo-controlled, parallel group, dose-response phase III A study to evaluate safety and efficacy of Prolonged Release (PR) OROS methylphenidate (18, 36 and 72 mg/day), with open-label extension, in adults with attention deficit/ hyperactivity disorder https://www.kusajili.fr:443/Trial/Mt3xA2b-dUm-AbiXBcp-cw%24a-multicentre-randomised-double-blind-placebo-controlled-parallel-group-dose-response-phase-iii-a-study-to-evaluate-safety-and-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message